Funder: Cancer Research UK
Due Dates: October 2, 2025 (Outline) | February 19, 2026 (Full) | March 26, 2026 (Outline) | September 1, 2026 (Full, projected)
Funding Amounts: Up to £1.75 million over 6 years (non-renewable); covers 50% salary, staff, running costs, equipment up to £50k, and limited relocation.
Summary: Supports established UK-based group leaders to advance independent, internationally competitive cancer research.
Key Information: Clinicians become ineligible after May 2026; host institution must contribute 50% salary and commit to long-term support.